Related references
Note: Only part of the references are listed.Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas
Troels Marstrand et al.
LEUKEMIA & LYMPHOMA (2014)
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
Thorbjorn Krejsgaard et al.
BLOOD (2013)
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
Katharina L. Kopp et al.
CELL CYCLE (2013)
miR-155 is involved in tumor progression of mycosis fungoides
Lilach Moyal et al.
EXPERIMENTAL DERMATOLOGY (2013)
Vascular endothelial growth factor receptor-3 expression in mycosis fungoides
Ida Holst Pedersen et al.
LEUKEMIA & LYMPHOMA (2013)
MicroRNAs as novel players in skin development, homeostasis and disease
M. R. Schneider
BRITISH JOURNAL OF DERMATOLOGY (2012)
MicroRNAs and autoimmunity
Angela Ceribelli et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
MicroRNAs and STAT interplay
Gary Kohanbash et al.
SEMINARS IN CANCER BIOLOGY (2012)
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ulrik Ralfkiaer et al.
BLOOD (2011)
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
Boye Schnack Nielsen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
Thorbjorn Krejsgaard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
miRNA expression profiling of mycosis fungoides
Marloes S. van Kester et al.
MOLECULAR ONCOLOGY (2011)
Evaluation of lymphangiogenic markers in Se,zary syndrome
Maria B. Karpova et al.
LEUKEMIA & LYMPHOMA (2011)
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome
M. G. Narducci et al.
CELL DEATH & DISEASE (2011)
Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis
Britt Lauenborg et al.
APMIS (2010)
COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)
K. L. M. Kopp et al.
LEUKEMIA (2010)
TARGETED THERAPIES Denileukin diftitox-a step towards a 'magic bullet' for CTCL
Marshall E. Kadin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Regulation of cytokines by small RNAs during skin inflammation
Rasmus O. Bak et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells
Michal Marzec et al.
CANCER RESEARCH (2008)
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
Shusheng Wang et al.
DEVELOPMENTAL CELL (2008)
Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome
T. Krejsgaard et al.
LEUKEMIA (2008)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
T. Krejsgaard et al.
LEUKEMIA (2006)
Increased sensitivity to interferon-a in psoriatic T cells
KW Eriksen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNα
C Brender et al.
LEUKEMIA (2005)
Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3
M Nielsen et al.
BLOOD (2002)
Share Paper
